Category Archives: Testosterone

Magnifier Research published a Global Testosterone Replacement Therapy Market Report 2020, Forecast to 2025 which provides a comprehensive study on the market, comprising a nitty-gritty and fair-minded evaluation of this market. The markets segmentation and the significant market verticals are considered while evaluating its industrial chain, production chain, manufacturing capacity, sales volume, and revenue. The research is a meticulous study of the global Testosterone Replacement Therapy market which portrays each and every detail of the market. It provides an overview of market segmentation such as type, application, and region. It also lists the drivers, limitations, and opportunities available in the market.

Some well-known companies identified to operate in the global market are: AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals

Factors that are contributing to the growth of a specific type of product category and factors that are motivating the status of the market highlighted in the report. The report covers the details on market acquisitions, mergers, and significant trends that are influencing the growth of the global Testosterone Replacement Therapy market in the coming years from 2020 to 2025. During the report compilation, analysts have used established and beneficial tools and techniques such as SWOT analysis and Porters Five Forces analysis to carry out the research study. The geographical scope of the products is also taken into consideration.

DOWNLOAD FREE SAMPLE REPORT: https://www.magnifierresearch.com/report-detail/40135/request-sample

On the basis of product type, this report displays the shipments, revenue (Million USD), price, and market share and growth rate of each type: Gels, Injections, Patches, Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, shipments, revenue (Million USD), price, and market share and growth rate for each application: Hospitals, Clinics, Others

An All-Inclusive Framework of The Geographical Terrain:

The global Testosterone Replacement Therapy market report covers market shares for global, North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa). The analysis of this report has been used to examine various segments that are relied upon to witness the quickest development based on the estimated forecast frame. Moreover, data concerning growth opportunities for the market across every detailed region is included in the report. The anticipated growth rate expected to be recorded by each region over the estimated years has been given within the research report.

ACCESS FULL REPORT: https://www.magnifierresearch.com/report/global-testosterone-replacement-therapy-market-report-2020-forecast-40135.html

Opportunities in The Global Testosterone Replacement Therapy Market Report:-

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team (sales@magnifierresearch.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Magnifier Research is a leading market intelligence company that sells reports of top publishers in the technology industry. Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Magnifier Research also specializes in analyzing hi-tech systems and current processing systems in its expertise. We have a team of experts that compile precise research reports and actively advise top companies to improve their existing processes. Our experts have extensive experience in the topics that they cover. Magnifier Research provides you the full spectrum of services related to market research, and corroborate with the clients to increase the revenue stream, and address process gaps.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@magnifierresearch.comWeb: http://www.magnifierresearch.com

See more here:
Global Testosterone Replacement Therapy Market 2020 Regional Analysis, Growth Prospects, Size, Outlook and Forecast 2025 - Galus Australis

Dublin, April 08, 2020 (GLOBE NEWSWIRE) -- The "Hormone Replacement Therapy Market Size, Share & Trends Analysis Report by Product (Estrogen, Human Growth), by Route Of Administration (Oral, Parenteral), by Type Of Disease, by Region, and Segment Forecasts, 2020 - 2027" report has been added to ResearchAndMarkets.com's offering.

The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027, expanding at a CAGR of 7.7%. A significant rise in the incidence rate of hormonal disorders in the newborns, adults, and elderly and populations is driving the market. The Prader-Willi syndrome (PWS) affects one in every 15,000 newborns, thereby boosting the demand for the therapy.

Estrogen replacement hormone therapy helps in reducing the vaginal indications of menopause, such as dryness, burning, itching, and pain during intercourse. Estrogen is available in the forms of pill, gel, skin patch, cream or spray form. It is highly successful for treating problematic menopausal night sweats and hot flashes. Around 45% of women between the ages of 40 to 60 years of age were reported taking counseling sessions from a physician regarding the advantages and disadvantages of using hormone replacement therapy (HRT) after menopause.

Growing awareness about menopausal signs and the treatment options is growing the HRT market. Owing to the significant development for ERT, there has been an initiation of very safe treatment options for the patients situated in various geographies of the world. For example, augmentation of innovative drug delivery systems like transdermal estrogen patches and vaginal estrogen drugs.

Further key findings from the report suggest:

Key Topics Covered:

1. Methodology and Scope

2. Executive Summary2.1 Market Outlook2.2 Segment Outlook2.2.1 Product2.2.2 Route of Administration2.2.3 Type of Disease2.2.4 Region2.3 Competitive Insights

3. Market Variables, Trends & Scope3.1 Market Segmentation3.2 Penetration & Growth Prospect Mapping3.2.1 Market Driver Analysis3.2.2 Market Restraint Analysis3.3 Hormone Replacement Therapy Market: Business Environment Analysis Tools3.3.1 Porter's Five Forces Analysis3.3.1.1 Bargaining power of suppliers3.3.1.2 Bargaining power of buyers3.3.1.3 Threat of new entrants3.3.1.4 Competitive rivalry3.3.1.5 Threat of substitutes3.3.2 PESTEL Analysis3.3.2.1 Political & legal3.3.2.2 Economic3.3.2.3 Technological

4. Hormone Replacement Therapy Market: Product Analysis4.1 Hormone Replacement Therapy Product Market Share Analysis, 2019 & 20274.2 Hormone Replacement Therapy Product Market: Segment Dashboard4.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Product Segment4.3.1 Estrogen Hormone Replacement Therapy4.3.1.1 Estrogen Hormone replacement therapy market, 2016 - 2027 (USD Million)4.3.2 HGH Replacement Therapy4.3.2.1 HGH replacement therapy market, 2016 - 2027 (USD Million)4.3.3 Thyroid Hormone Replacement Therapy4.3.3.1 Thyroid hormone replacement therapy market, 2016 - 2027 (USD Million)4.3.4 Testosterone Hormone Replacement Therapy4.3.4.1 Testosterone hormone replacement therapy market, 2016 - 2027 (USD Million)

5. Hormone Replacement Therapy Market: Route of Administration Analysis5.1 Hormone Replacement Therapy Route of Administration Market Share Analysis, 2019 & 20275.2 Hormone Replacement Therapy Route of Administration Market: Segment Dashboard5.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Route of Administration Segment5.3.1 Oral5.3.1.1 Oral market, 2016 - 2027 (USD Million)5.3.2 Parenteral5.3.2.1 Parenteral market, 2016 - 2027 (USD Million)5.3.3 Transdermal5.3.3.1 Transdermal market, 2016 - 2027 (USD Million)5.3.4 Others5.3.4.1 Others market, 2016 - 2027 (USD Million)

6. Hormone Replacement Therapy Market: Type of Disease Analysis6.1 Hormone Replacement Therapy Type of Disease Market Share Analysis, 2019 & 20276.2 Hormone Replacement Therapy Type of Disease Market: Segment Dashboard6.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Type of Disease Segment6.3.1 Menopause6.3.1.1 Menopause market, 2016 - 2027 (USD Million)6.3.2 Hypothyroidism6.3.2.1 Hypothyroidism market, 2016 - 2027 (USD Million)6.3.3 Male Hypogonadism6.3.3.1 Male hypogonadism market, 2016 - 2027 (USD Million)6.3.4 Growth Hormone Deficiency6.3.4.1 Growth hormone deficiency market, 2016 - 2027 (USD Million)6.3.5 Others6.3.5.1 Others market, 2016 - 2027 (USD Million)

7. Hormone Replacement Therapy Market: Regional Analysis7.1 Hormone Replacement Therapy Regional Market Share Analysis, 2019 & 20277.2 Hormone Replacement Therapy Regional Market: Segment Dashboard7.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)7.4 Market Size, & Forecasts, and Trend Analysis, 2016 to 20277.4.1 North America7.4.1.1 North America hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.1.1.1 U.S.7.4.1.1.1.1 U.S. hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.1.1.2 Canada7.4.1.1.2.1 Canada hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.2 Europe7.4.2.1 Europe Hormone Replacement Therapy market, 2016 - 2027 (USD Million)7.4.2.1.1 U.K.7.4.2.1.1.1 U.K. hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.2.1.2 Germany7.4.2.1.2.1 Germany hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.3 Asia Pacific7.4.3.1 Asia Pacific hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.3.1.1 Japan7.4.3.1.1.1 Japan hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.3.1.2 China7.4.3.1.2.1 China hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.4 Latin America7.4.4.1 Latin America hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.4.1.1 Brazil7.4.4.1.1.1 Brazil hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.4.1.2 Mexico7.4.4.1.2.1 Mexico hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.5 Middle East and Africa (MEA)7.4.5.1 MEA hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.5.1.1 South Africa7.4.5.1.1.1 South Africa hormone replacement therapy market, 2016 - 2027 (USD Million)7.4.5.1.2 Saudi Arabia7.4.5.1.2.1 Saudi Arabia hormone replacement therapy market, 2016 - 2027 (USD Million)

8. Competitive Analysis8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players8.2 Vendor Landscape8.3 Company market position analysis (Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)8.4 Company Profiles

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/ta9bk1

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Link:
Global Hormone Replacement Therapy Market (2020 to 2027) - by Product, Route of Administration, Type of Disease, Region and Segment Forecasts - Yahoo...

The global Testosterone Replacement Therapy Market research report thoroughly explains each and every aspect related to the Testosterone Replacement Therapy Market, which facilitates the reports reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. The growth trend forecasted on account of thorough examination offers in-depth information regarding the global Testosterone Replacement Therapy Market. A pathway of development is offered by the market to the several connected networks of businesses under it, which include different firms, industries, organizations, vendors, distributors, and local manufacturers too. All the key Testosterone Replacement Therapy Market players compete with each other by offering better products and services at a reasonable price in order to grab significant share at the regional and global level market.

Furthermore, functional causes of hypogonadism are mainly attributed to the severe psychological or emotional stress, obesity (WHO grade III or IV- BMI > 30), nutritional deficiency or eating disorders, untreated obstructive sleep apnea, medication such as opioids, androgens, glucocorticoids, anabolic steroids; chronic systemic illness caused due to kidney, lung, heart failure, diabetes mellitus, HIV infection, Crohns disease, and aging.

Get a Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/2024

The report incorporates an estimated impact of strict standards and regulations set by the government over the market in the upcoming years. The market report also comprises exhaustive research done using several analytical tools such as SWOT analysis to identify the market growth pattern.

Top Manufactures in GlobalTestosterone Replacement TherapyMarket Includes:AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Regions & Countries Mentioned In The Testosterone Replacement Therapy Market Report:

North America ( United States)

Europe ( Germany, France, UK)

Asia-Pacific ( China, Japan, India)

Latin America ( Brazil)

The Middle East & Africa

Key Highlights of the Table of Contents:

Testosterone Replacement Therapy Market Study Coverage: It includes key manufacturers covered, key market segments, the scope of products offered in the global market, years considered, and study objectives. Furthermore, it tuches the segmentation study provided in the report on the basis of the type of product and applications.

Testosterone Replacement Therapy Market Executive Summary: This section emphasizes on the key studies, market growth rate,Competitive landscape, market drivers, trends, and issues.

Testosterone Replacement Therapy Market Production by Region: The report provides information related to import and export, production, revenue, and key players of all regional markets studied are covered in this section.

Testosterone Replacement Therapy Market Profile of Manufacturers: Analysis of each market player profiled is detailed in this section. This also provides SWOT analysis, products, production, value, capacity, and other vital factors of the individual player.

Buy This Complete A Business Report: https://www.coherentmarketinsights.com/insight/buy-now/2024

Table of Contents

Report Overview:It includes the Testosterone Replacement Therapy market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary:This section of the report gives information about Testosterone Replacement Therapy market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

Profiles of International Players:Here, key players of the Testosterone Replacement Therapy market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

Regional Study:All of the regions and countries analyzed in the Testosterone Replacement Therapy market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

An Overview of the Impact of COVID-19 on this Market:

The pandemic of COVID-19 continues to expand and impact over 175 countries and territories. Although the outbreak appears to have slowed in China, COVID-19 has impacted globally. The pandemic could affect three main aspects of the global economy: production, supply chain, and firms and financial markets. National governments have announced largely uncoordinated, country-specific responses to the virus. As authorities encourage social distancing and consumers stay indoors, several businesses are hit. However, coherent, coordinated, and credible policy responses are expected to offer the best chance at limiting the economic fallout.

National governments and international bodies are focused on adopting collaborative efforts to encourage financial institutions to meet the financial needs of customers and members affected by the coronavirus. However, there are some sectors that have remained unscathed from the impact of the pandemic and there are some that are hit the hardest.

We, at Coherent Market Insights, understand the economic impact on various sectors and markets. Using our holistic market research methodology, we are focused on aiding your business sustain and grow during COVID-19 pandemics. With deep expertise across various industries-no matter how large or small- and with a team of highly experienced and dedicated analysts, Coherent Market Insights will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Access insightful study with over 100+ pages, list of tables & figures, profiling 10+ companies https://www.coherentmarketinsights.com/insight/request-pdf/2024

About CMI:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:Coherent Market Insights 1001 4th Ave,#3200 Seattle, WA 98154,U.SPhone: US +12067016702 / UK +4402081334027Email: sales@coherentmarketinsights.com

More here:
Latest Update 2020: Testosterone Replacement Therapy Market By Covid19 Impact Analysis And Top Manufacturers: Endo Pharmaceuticals, Inc., Eli Lilly...

NEW YORK, April 7, 2020 /PRNewswire/ --Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Estrogen, Human Growth), By Route Of Administration (Oral, Parenteral), By Type Of Disease, By Region, And Segment Forecasts, 2020 - 2027

Read the full report: https://www.reportlinker.com/p05879593/?utm_source=PRN

The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027, expanding at a CAGR of 7.7%. A significant rise in the incidence rate of hormonal disorders in the newborns, adults, and elderly and populations is driving the market. The Prader-Willi syndrome (PWS) affects one in every 15,000 newborns, thereby boosting the demand for the therapy.

Estrogen replacement hormone therapy helps in reducing the vaginal indications of menopause, such as dryness, burning, itching, and pain during intercourse.Estrogen is available in the forms of pill, gel, skin patch, cream or spray form.

It is highly successful for treating problematic menopausal night sweats and hot flashes. Around 45% of women between the ages of 40 to 60 years of age were reported taking counseling sessions from a physician regarding the advantages and disadvantages of using hormone replacement therapy (HRT) after menopause.

Growing awareness about menopausal signs and the treatment options is growing the HRT market.Owing to the significant development for ERT, there has been an initiation of very safe treatment options for the patients situated in various geographies of the world.

For example, augmentation of innovative drug delivery systems like transdermal estrogen patches and vaginal estrogen drugs.

Further key findings from the report suggest: The estrogen replacement therapy segment dominated the overall market in terms of revenue share in the year 2019. On the other hand, the parenteral segment is likely to showcase the fastest growth rate over the forecast period from 2020 to 2027, owing to the rising number of hormonal disorders Menopause is likely to showcase the fastest growth rate over the forecast period. Women are vulnerable to certain diseases and conditions such as osteoporosis and hot flashes during and after menopause. About 73% of postmenopausal women suffer from hot flashes North America dominated the overall hormone replacement therapy market in terms of revenue share in the year 2019. The increase in the incidence rate of hypogonadism due to a rise in obesity and poor health in the geriatric population drive the market. According to the American Academy of Family Physicians, more than 2.5 million Americans received testosterone treatment in U.S alone in 2014 Some of the key players in this market are Abbott Laboratories; Novartis; Pfizer, Inc.; Mylan Laboratories; Merck and Co.; Novo Nordisk; Bayer Healthcare; Eli Lilly; and Genentech.

Read the full report: https://www.reportlinker.com/p05879593/?utm_source=PRN

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/hormone-replacement-therapy-market-size-share--trends-analysis-report-by-product-by-route-of-administration-by-type-of-disease-by-region-and-segment-forecasts-2020---2027-301036616.html

SOURCE Reportlinker

Read more:
Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product, By Route Of Administration, By Type Of Disease, By Region And...

Global Testosterone Replacement Therapy Market presenting the fundamental market overview, market trends, past, present and forecast data related to the Testosterone Replacement Therapy Market From 2020-2025. A complete analysis of the Testosterone Replacement Therapy based on the definition, product specifications, market gains, key geographic regions, and imminent Testosterone Replacement Therapy players will drive key business decisions.

Global Testosterone Replacement Therapy market report presents a thorough and latest market insights in the form of graphs, pie charts, tables to provide a clear picture of the Testosterone Replacement Therapy Market. Global Testosterone Replacement Therapy report is divided into different chunks based on the type, diverse applications, key geographical regions, market share of each player, their production volume, and supply-demand ratio.

Dont Miss Out On Business Opportunities In Testosterone Replacement Therapy Market | Get FREE Sample Pages At: @ https://www.eonmarketresearch.com/sample/58743

Global Testosterone Replacement Therapy Market Report is Segmented Into Different Parts As Below:

Testosterone Replacement Therapy Market Details Based On Key Players:

AbbVieAllerganBayerEli Lilly and CompanyKyowa Kirin InternationalNovartisPfizer

Testosterone Replacement Therapy Market Based On Product Type:

General Type

Testosterone Replacement Therapy Market Based On Product Applications:

Medical

In this study, the years examined to evaluate the market size of Testosterone Replacement Therapy are as per follows:

History Year: 2014-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2020 to 2025

Inquiry before Buying Testosterone Replacement Therapy Market 2020 Report and Ask For Discount Here @ https://www.eonmarketresearch.com/enquiry/58743

The Global Testosterone Replacement Therapy Market Report Covers The Following Data Points:

Section 1: This section covers the Global Testosterone Replacement Therapy Market overview, including the basic market introduction, market analysis by its applications, type, and regions. The major regions of the Global Testosterone Replacement Therapy Market include, Europe, Asia, Middle East & Africa. Testosterone Replacement Therapy Market statistics and outlook (2020-2025) are presented in this section. Testosterone Replacement Therapy market dynamics states the opportunities, key driving forces, market risk are studied.

Section 2: This section covers Testosterone Replacement Therapy manufacturers profile based on their business overview, product type, and application. Also, the sales volume, Testosterone Replacement Therapy product price, gross margin analysis, and Testosterone Replacement Therapy market share of each player is profiled in this report.

Section 3 and Section 4: These sections present the Testosterone Replacement Therapy competition based on sales, profits, and market division of each manufacturer. It also covers the Testosterone Replacement Therapy market scenario based on regional conditions. Region-wise Testosterone Replacement Therapy sales and growth (2020-2025) are studied in this report.

Section 5 and Section 6: These two sections cover the Testosterone Replacement Therapy Market by countries. Under this, the Testosterone Replacement Therapy revenue, the market share of the countries like United States, Canada & Mexico are provided.

Section 7, Section 8 and Section 9: These 3 sections covers Testosterone Replacement Therapy sales revenue and growth in all the regions. Under these regions Testosterone Replacement Therapy report covered, the growth and sales in these regions are illustrated in this Testosterone Replacement Therapy Market report.

Section 10 and Section 11: These sections depict the Testosterone Replacement Therapy market share, revenue, sales by product type and application. The Testosterone Replacement Therapy sales growth seen during 2015-2020 is covered in this report.

Section 12 and Section 13: These sections provide forecast information related to Testosterone Replacement Therapy market (2020-2025) for each region. The sales channels include direct and indirect Testosterone Replacement Therapy marketing, traders, distributors, and development trends are presented in this report.

Section 14 and Section 15: In these sections, Testosterone Replacement Therapy market key research conclusions and outcome, analysis methodology, and data sources are covered.

*** Thank you for reading. You may also request custom information, such as chapter-wise or unique region-wise research, depending on your interest. ***

Contact Us:

Eon Market ResearchPhone: +1 703 879 7090Email: sales@eonmarketresearch.com

See the rest here:
Global Testosterone Replacement Therapy Market Research Report By Key Players, Geographical Regions and Growth Analysis Outlook Up To 2025 - Fashion...

March 31 was International Transgender Day of Visibility. Minus a few posts online by media outlets, little was said about it this year. As a public health student, I have been wondering how marginalized communities will be negatively affected by COVID-19 and how some communities needs will be overshadowed as healthcare systems become overwhelmed and medical resources are focused on treating coronavirus patients.

Ryan Sutherland

One of the communities that will undoubtedly face increased pressure is the transgender and non-binary community as a result of restrictive coronavirus lockdowns, disrupted access to social services, barriers to prescribing and managing hormone therapy medications, and hospital decisions to halt gender-affirming surgeries.

And in some ways, stay-at-home orders and enforced social distancing policies, while they effectively reduce opportunities for viral transmission, also contribute to trans erasure and create more opportunities for the existence of members of the trans and non-binary communities to be ignored, denied or minimized. What isnt seen isnt heard, and only through increased visibility comes equal rights.

Recently, Gov. Brad Little of Idaho signed into law House Bill 500, the Fairness in Womens Sports Act, and House Bill 509, the Idaho Vital Statistics Act. H.B. 500 states that athletic teams or sports designated for females, women, or girls shall not be open to students of the male sex and that disputes can be resolved by inspecting the students reproductive anatomy, genetic makeup, or normal endogenously 19 produced testosterone levels, effectively banning female-identifying transgender athletes from performing on teams aligned with their chosen gender identity.

H.B. 509 prohibits transgender individuals from changing their gender on their birth certificates. These bills originated from complaints strikingly similar to those articulated in a recent lawsuit filed against the Connecticut Association of Schools, Connecticut Interscholastic Athletic Conference and the boards of education in Bloomfield, Cromwell, Glastonbury, Canton and Danbury aimed to block transgender athletes from participating in girls sports.

With more than 40 states that have introduced similar legislation this year, statewide stay-at-home orders and social distancing policies limit the ability for transgender activists to protest and overturn discriminatory legislation such as these bills. And the media focus on COVID-19 developments might allow this type of legislation to fall through the cracks.

Additionally, trans and non-binary workers are three times more likely to be unemployed compared to the general population, and a lack of employer-based insurance results in a disproportionate insurance coverage gap. The pandemic has only exacerbated existing disparities. The International Foundation for Employee Benefit Plans reported that transgender inclusive healthcare benefits are offered to less than one-third of U.S. employees. With widespread furloughing and unemployment in response to the pandemic, even those with insurance benefits that cover hormone replacement therapy (HRT), counseling, or gender-affirming surgery are at risk of losing coverage.

While over 3 million Americans filed for unemployment as a direct result of layoffs caused by COVID-19, applying for unemployment might create unique challenges for trans individuals who might be required to use their deadname, a name assigned at birth that has electively been changed to match their gender identity, to prove their identity on government forms this can undoubtedly be traumatizing. Furthermore, trans and non-binary individuals might be wary to seek unemployment help as waiting in long lines outside unemployment offices might put them at an increased risk of discriminatory violence.

And it is no secret that, as a result of social stigma and discrimination, the transgender population has a higher rate of unstable housing and homelessness. According to the Williams Institute, over 30% of individuals served by drop-in centers, street outreach workers, and housing programsidentified as LGBT. Unfortunately, those who are transgender and homeless are at increased risk of exploitation, violence, and abuse, and may be turned away from shelters as a result of their gender identities. As some homeless shelters close or limit occupancy to stop the spread of COVID-19, this further limits available housing options for unhoused transgender individuals.

Past negative experiences of being misgendered or refused service when seeking care or out of fears of contracting COVID-19 in healthcare settings may cause trans people to forego care. And trans individuals may be reluctant to go to hospitals and clinics to request hormone replacement therapy (HRT) treatment during the pandemic already overburdened hospitals might not have the capacity to provide sufficient social services or hormone treatments.

Furthermore, gender-confirmation surgeries, deemed non-essential and elective, have been delayed or cancelled at many U.S. hospitals due to coronavirus. Interruptions in HRT provision or postponing long-awaited gender-affirming surgeries could augment feelings of isolation and gender dysphoria and amplify psychological distress. The Trevor Projects 2019 survey reported that more than half of transgender and non-binary young people have contemplated suicide and one-third have attempted it.

The minority stress model, a social psychology theory widely adopted in public health, describes how extreme minority stress causes adverse health outcomes among stigmatized minority groups. Consistent stress, discrimination and internalized stigma faced by transgender people increases their risk of suicidality. And as health systems react to treat coronavirus patients and critical services previously available to transgender patients are interrupted or deprioritized, feelings of isolation and marginalization might further increase rates of suicide or affect transgender mental and physical health and wellbeing.

School closures might also pose unique challenges to transgender youth. With campus LGBTQ resource centers and peer support unavailable and the suspension of all school-based social activities, transgender students might feel unsupported. Furthermore, self-quarantining with abusive family members who do not affirm their trans identity can be extremely traumatizing to trans youth.

As one trans commenter pointed out on a recent Buzzfeed article, I have to make a decision about whether to stay in the UK where I study or fly back to the States to be with my parents, one of whom doesnt use my name or pronouns and has refused to do so. With campuses and dormitories closed to suppress viral transmission, some transgender students must return home to unsafe emotionally and physically abusive homes because they are left with nowhere else to go. And once there, due to enforced lockdowns, they potentially cannot leave.

Quarantine and lockdowns may also increase rates of domestic and intimate partner violence perpetuated against transgender individuals. According to conservative estimates, the National Coalition Against Sexual Violence reports that one in three women and one in nine men will experience sexual violence during their lifetime, and these estimates do not accurately capture the increased risk of sexual violence within the LGBTQ community. Lockdowns and social distancing policies, budget cuts to IPV-related social services and mental health counseling, and financial instability due to unemployment all create opportunities for abusers to perpetrate sexual violence and make it more difficult for transgender victims to leave abusive relationships or report abuse.

Lastly, conservative graphs from the Imperial College COVID-19 Response Team and others by the Centers for Disease Control and Prevention (CDC) show frightening estimates that up to 2.2 million Americans mainly older adults, those who are immunocompromised, or those who have other pre-existing health conditions such as diabetes or lung disease might die as a result of contracting COVID-19. Elderly trans individuals at higher risk of contracting COVID-19 might refuse help from aging providers such as meal delivery programs, senior centers, or other social programs because they are afraid of harassment or discrimination.

Furthermore, statistics show the LGBTQ community is 50% more likely to smoke than the general population, potentially resulting in increased susceptibility to respiratory failure brought on by COVID-19, a respiratory illness. Moreover, trans individuals are more likely than the general population to be diagnosed with cancer and HIV, and reduced immune function could put them at a higher risk to contract coronavirus and face harsher symptoms.

Overall, the coronavirus has not just affected the trans and non-binary communities by restricting access to gender-affirming surgeries or HRT, but has effectively reduced their visibility. Fears of being misgendered or mistreated when seeking unemployment benefits or care in healthcare settings may cause trans and non-binary people to forego seeking assistance during this crisis.

Disruptions in hormone replacement therapy (HRT), counseling, or gender-affirming surgeries and self-quarantining with abusive family members may increase psychological distress and can augment rates of suicidality. Widespread unemployment might result in a loss of employer-based insurance coverage of hormone therapy and gender-affirming surgeries and cause an increase in homelessness among this population. And transphobic legislation may pass in the absence of assembled protestors who remain sequestered at home due to public health efforts to stop the spread of the coronavirus.

While COVID-19 has had a pronounced effect on everyone, those most vulnerable, such as those in the trans community, are poised to receive the most collateral damage.

Ryan Sutherland is a Master of Public Health candidate at the Yale School of Public Health in the Social and Behavioral Science Department with a concentration in global health.

CTViewpoints welcomes rebuttal or opposing views to this and all its commentaries. Read our guidelines andsubmit your commentary here.

Originally posted here:
What isn't seen isn't heard: trans and non-binary health amid COVID-19 - The CT Mirror

The educational program seeks to enlighten viewers on the advancements in hormone replacement.

FORT LAUDERDALE, Fla. (PRWEB) April 02, 2020

Best known for his parts in various films like "Boyz in the Hood", "Deep Cover", "Contagion", and in his inimitable portrayal of Morpheus, Laurence Fishburne is the host of the show "In Depth". The educational program dives into a wide array of topics that affect people living around the globe today. An impending episode will shift to the world of medicine and will interview medical professionals about hormone replacement therapies.

It is no question that modern medicine helps save numerous lives and aids people to manage the pains and symptoms associated with getting older. Hormone replacement therapy (HRT) is a development in medicine that has been aiding women for several decades. HRT is used to help maintain the balance of estrogen and progesterone in women who are experiencing perimenopause or menopause.

Menopause is an unavoidable part of life for women, and the symptoms associated can be bothersome. This type of hormone therapy can help reduce the symptoms related to the natural process, such as hot flashes, sweating, and mood swings. Also, HRT can help reduce the risk of osteoporosis. Some forms of HRT utilize both estrogen and progesterone, while others use only estrogen or testosterone. HRT may also help in maintaining the skin's youthful appearance, but it cannot delay aging.

The show will provide more education about available hormone replacement therapies in the new episode of "In Depth" with Laurence Fishburne.

The educative television program "In Depth" with host Laurence Fishburne is given careful inspection before broadcast. "In Depth" has received a multitude of awards for achievement in production quality and content.

For the original version on PRWeb visit: https://www.prweb.com/releases/experts_talk_about_hormone_replacement_therapies_on_in_depth_with_laurence_fishburne/prweb17018316.htm

The rest is here:
Experts Talk About Hormone Replacement Therapies On "In Depth" With Laurence Fishburne - Benzinga

UFC president, Dana White is a polarizing figure. Hes done a tremendous amount for the UFC and the sport of MMA in general. Yet the way he conducts himself, some of his comments and antics, rubs people up the wrong way. But Dana White is Dana White and hes unapologetic about that fact. Hes achieved a great deal of success to date, so he isnt about to simmer down.

Cross Dana White at your peril. A lot of UFC fighters havent heeded this advice. It doesnt make any sense to bite the hand that feeds you. But some fighters think theyre entitled, think theyre the real deal, and take issue with some of Danas comments and practices. Whatever the reasons may be, these 16 fighters have come under fire from the UFC president, have felt Dana Whites wrath. Some are out of the doghouse, but others on this list have remained in Danas bad books. These are 16 fighters whove found themselves in Dana Whites doghouse.

The beef between these two supposedly started due to contractual issues. Randy announced hed be moving on from the UFC because he wanted a fight with Fedor Emelianenko. But Dana thought he had different motives, that he wanted to get involved with Hollywood and was meeting someone from the industry that Dana had issues with in the past.

Unsavoury things happen in the Octagon from time to time. But fighters still have to keep their cool, have got to maintain their professionalism. Paul Daley ended up in the doghouse after he sucker-punched an opponent way after the bell. Dana said that Paul was done, that he was finished with the UFC, and regardless of how good he was, he wasnt coming back.

The Tito Ortiz- Dana White feud is perhaps one of the biggest involving the UFC president. Theyve had a longstanding rivalry and part of the reason for this is because Titos been very outspoken regarding the treatment of fighters by the UFC. He was in Danas doghouse, and Dana was even set to release him at one point because a fight between the two was on the cards!

RELATED: The 16 Biggest Feuds Of Dana White's Career

Lyoto ended up in the doghouse when he accepted a fight at short notice, then demanded more money because of it. This no-doubt angered Dana who refused to shell out the cash and adhere to Lyotos demands. Lyoto didnt get the cash and he didnt get the fight. Dana ended up going elsewhere.

Way back in 2002, Josh Barnett was a UFC Champion. But his career was soon over. Josh tested positive for performance enhancers three times. When giving interviews on the matter, he seemed very blas, refused to acknowledge what hed done and denied it every time. Dana White was incensed and soon let Josh Barnett go.

Former Pride 205 and 185-pound champion Dan Henderson landed up in Dana Whites doghouse for quite some time. Once upon a time there were talks of Dan resigning for the UFC. Dana White admits pushing him to sign for Strikeforce. In a way, he forced his hand. He just didnt want to be associated with Dan. But he later resigned and headlined at UFC 139 and seemingly, all was forgotten.

Michael Bispings ludicrous actions at UFC 127 landed him in Danas doghouse and in plenty of hot water. The guy just lost it, and Dana subsequently lost it with Michael, and rightly so. Michael performed an illegal move on Jorge Rivera and then proceeded to spit on his opponents team in their corner.

Quinton Rampage Jackson went on something of a rampage. Hes got a big personality, as has Dana, and they frequently clashed. But Dana found it hard to forgive him when he was involved in a hit-and-run and subsequently led police on a high-speed chase. In time, Quinton was let out of Danas doghouse.

Although he was a champion and one of the greatest MMA fighters around, that didnt stop him from finding a place in Dana Whites doghouse. The two have been involved in one seriously bitter rivalry. Theyve been engaged in a war of words for many years. Dana hates his guts, thinks hes just generally a bad person.

Dana White has a tremendous amount of love and respect for Anderson Silva. Hes achieved great things in the Octagon. But Dana hasnt always been enamored by Andersons fighting style. At UFC 112, Dana actually got up and left during the fight because he deemed it to be an absolute snooze-fest. It marked a period where Anderson had gone off the boil a tad. Dana actually apologized to the fans for having to witness such a dire showdown.

Dennis Hallman was deemed to be a decent fighter, hence he was contracted with the UFC. But he had a bit of a whacky mind, certainly a crazy dress sense. His choice of attire for his fight at UFC 133 landed him in Danas doghouse. He wore really short shorts, almost a speedo that left little to the imagination. Dennis ended up getting knocked out, and Dana was incredibly happy about that as it meant Dennis didnt spend much time on television.

RELATED: 15 UFC Fighters Dana White Can't Afford To Lose

Brock Lesnars had his ups and downs, be it in wrestling or on the MMA scene. But hes a star performer, is always going to be the major attraction at any event. But that hasnt made him exempt from Danas doghouse. He found himself in there for a momentary period after bashing the UFCs sponsors. They had a whip the dog session, then moved on.

According to Dana White, dealing with Cris Cyborg has been a nightmare. He said theres always controversy surrounding Cris, just a build up of a lot of things. Dana isnt having to deal with Cris anymore though as she was recently let go and has signed a multi-fight deal with Bellator MMA.

Nate Marquardt was once on a course of testosterone replacement therapy. Thats all well and good, its totally legal. But a fighters testosterone levels have got to return to normal before they fight. Nate and his team didnt ensure this happened. Dana was disgusted and had to cut him from his scheduled fight, and subsequently, from the UFC.

Jon Jones has found himself in Dana Whites doghouse time and time again. After his recent misdemeanors, he may not be let out. Whether hes a champion or not, regardless of whether hes one of the worlds greatest MMA competitors, Dana can only put up with so much, might just chain that doghouse and throw away the key.

Conor McGregors a big, bolshie character. Its partly why hes one of the biggest MMA fighters, certainly one of the most popular, on the planet. But this personality has gotten him into hot water with Dana White on a few occasions. Hes committed driving offenses, there was that incident at Bellator 187, and not forgetting the bus attack at UFC 223 Media Day.

Sources - MMA Fighting, MMA Mania, Bleacher Report

NEXT:10 UFC Stars Who Got Along With Ronda Rousey (And 7 Who Didn't)

Next16 Breathtaking Pics Of UFC Star Mackenzie Dern

Excerpt from:
16 Fighters Whove Found Themselves In Dana Whites Doghouse - TheThings

This article originally appeared on VICE US.

If you follow enough trans women on Twitter, you might have seen a panic break out earlier this week over concerns that spironolactone, a testosterone blocker that many of us take as part of hormone replacement therapy that is also widely prescribed to the general population to treat hormonal acne, increases ones risk for developing COVID-19. Thankfully, according to the medical experts VICE spoke with, there is absolutely no cause for concern.

The mess, like many before it, all began on Instagram. Ellen Marmur, a New York City dermatologist, posted a video to her feed on March 21 in which she recommends that her patients stop taking spironolactone, also called spiro. The potassium-sparing diuretic was initially developed in 1957 to treat hypertension and congestive heart failure.

I would stop spironolactone, Marmur says in the video. It is not medically necessary for acne. I am only talking about my acne patients. I would stop the spironolactone until we know further.

As Marmur explains in the video, her recommendation is based on her own research into spironolactones effect on angiotensin converting enzyme 2 (ACE2) receptors, which appear to serve as one possible entry point for SARS-CoV-2, the novel coronavirus that can cause COVID-19. This is not a recommendation shared by the American Academy of Dermatology, she notes at the top of the clip; she merely speaks for herself. A number of outlets ran with the recommendation shortly after Marmur posted the video to her Instagram account, which has nearly 16,000 followers at press time. Pop Sugar and RealSelf told readers that they might want to stop taking spiro as a precautionary measure against COVID-19. Neither site makes note of the key role spiro plays in trans healthcare, nor does Marmur in her Instagram video.

In the days that followed, an increasing number of trans people started sharing the RealSelf and Pop Sugar articles on social media, anxiously wondering whether a medication that many consider to be life-saving may actually be putting their lives at risk. The concern is more than valid. Trans healthcare and its impact on actual trans people has been woefully under-researched since its inception, leading many trans individuals to trust anecdotal information from other community members as much as if not more than the recommendations they get directly from providers. Given our constantly evolving understanding of the coronavirus pandemic, not to mention spiros negative reputation in many pockets of the community, we would have every reason to worry after reading RealSelf or Pop Sugars alarming and, frankly, irresponsible reporting.

VICE spoke with medical providers who oversee trans healthcare and other services at two LGBTQ community health centers, both of whom agreed that there is no reason to believe that taking spiro will make any individual, trans or cis, any more susceptible to COVID-19. The data is still inconclusive regarding the role of ACE2 receptors and coronavirus susceptibility, said Julie Thompson, Medical Director of Trans Health at Fenway Health in Boston. Asa Radix, Senior Director of Research and Education at Callen-Lorde Community Health Center in New York City, echoed Thompsons sentiments: I would not want someone to stop the medication based on no evidence.

The argument that spiro might make one more vulnerable to the virus may appear to be scientifically sound at first, with many credible citations to back it up. But in the words of Cher Horowitz, its a full-on Monet: From far away its OK, but up close? Its a big old mess. Marmurs claim likely draws on a study from 2005 about how spiro increases the activity and expression of your cells ACE2 receptors, which, as discussed earlier, are believed to be key to the novel coronavirus replication process. (Radix was skeptical about this study during our interview, noting that it only involved 10 patients.) Using a kind of transitive logic, the people making the case against spiro then connect that studys findings to current research into whether medications that affect ACE2 receptors might increase risk for COVID-19 infection. In other words, if A equals B and B equals C, then spiro might make you more susceptible to COVID-19.

The problem here is that no matter how scary that risk sounds, its still theoretical. Nobody has conclusively proven that taking spiro, or any other medication that affects our ACE2 receptors, will make us more likely to get infected. And given how long it would take to conduct a study and produce any credible evidence one way or the other, nobody will be able to conclusively prove it any time soon.

On March 17, the American Heart Association, the American College of Cardiology, and the Heart Failure Society of America released a joint statement addressing concerns about ACE2 receptor-interactant medications and COVID-19 risk, telling patients to continue taking ACE inhibitors and angiotensin-receptor blockers (ARBs) as prescribed. Radix of Callen-Lorde told VICE that trans people currently taking spiro should continue to do so, as well. Rather than worry about a theoretical risk, he recommended that we instead focus our attention on the very real health risks trans people will face in this pandemic.

Trans people have always had inadequate healthcare and are generally discriminated against in our systems, all of which will continue, he said. Imagine if you were a trans person whod had negative healthcare experiences, and you developed COVID-19. Youre probably sitting at home and worrying about whether you should even go to the emergency room. Those are the issues we should be concerned about: encouraging trans people to seek out healthcare if they need it.

Thats not theoretical. Thats real.

Follow Harron Walker on Twitter .

Originally posted here:
A Dermatologist Is Creating Unnecessary Panic Around Spironolactone and COVID-19 - VICE

Talk to anyone whose been around for a few decades, and youll usually hear that life gets sweeter with age. Even with the inevitable slowdown that starts in your 30s, your best years can still be ahead.

Perhaps youve noticed that slowdown: If you become fatigued more easily than you used to, your mind isnt as sharp, or your libido is on the decline, it could be because of low testosterone.

As you grow, your brain periodically produces signal hormones responsible for stimulating testosterone production, according to Vital4Men. Testosterone is the main hormone responsible for the growth and development of male sex organs, muscle mass, and bone density. It also gives you energy and affects your mood.

When testosterone reaches an acceptable range, brain signals slow down, which allows your testosterone to lower. However, that decrease could lead to testicular problems at this stage. This low level of testosterone production is called hypogonadism.

Signs you may have low testosterone

The symptoms of low testosterone or hypogonadism include the following:

You may not think that you have low testosterone if you ignore symptoms or simply attribute them to aging. Unfortunately, hoping these issues will go away on their own wont work and, in fact, you may notice they just get worse.

Your testosterone levels will likely continue to decline over time and the severity of your symptoms will most likely continue to increase, Vital4Men says.

However, if you pay attention, the good news is that low testosterone is treatable, so you can feel like yourself again and look forward to the years ahead.

One of the best treatments is testosterone replacement therapy.

What is testosterone replacement therapy?

Testosterone replacement therapy can improve the symptoms of low testosterone. Doctors may prescribe testosterone through injections, gels, patches, surgically implanted pellets, or oral options to improve hormone levels.

The treatment process is simple. For example, when you visit Vital4men, the medical professionals will perform a blood test to determine if you are an eligible candidate for testosterone replacement therapy, and youll receive your results within a few days.

If your testosterone levels fall outside the normal range, you may be a candidate for treatment. Your doctor will go over potential side effects to determine if testosterone replacement therapy is the right option.

At the viTal4men clinic, we treat low testosterone levels with testosterone replacement therapy to get you back to your optimum level, the company says. We are a complete mens wellness center.

The clinic will support you through the entire process. The best part, though, is the results. While your outcome will be individual, there are many potential benefits to testosterone replacement therapy:

If youre experiencing any of the symptoms of low testosterone, dont give up hope. Visit Vital4Men for more information and to schedule a free testosterone level test.

Excerpt from:
What is testosterone replacement therapy, and do you need it - KTAR.com